Experimental Biologic Surpasses Ustekinumab for Psoriasis Experimental Biologic Surpasses Ustekinumab for Psoriasis

A biologic under investigation for severe psoriasis has topped one of the most effective therapies on the market in head-to-head phase 3 trials.Medscape Medical News

Source: Medscape Allergy Headlines - February 20, 2018 Category: Allergy & Immunology Tags: Dermatology News Source Type: news